Form 4 for RMD ResMed|
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001127602-22-016949 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-07 | 2022-06-03 | RMD | PENDARVIS DAVID | Chief Administrative Off | S - Sale | $209.44 | -1,545 | 108.4K | -1% | -$323.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-06-03 | S | D | 1,545 | $209.44 | 108,376 | D | — | — | (F2) Includes 62.7151 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan. |